Lady Gaga's Partner Trains AI on Living Human Tissue
Michael Polansky, founder of Outer Biosciences, is using living tissue that can be kept alive outside the body for over a month to train an AI model, leveraging his background in applied mathematics and computer science from Harvard

Michael Polansky, the partner of Lady Gaga and founder of Outer Biosciences, is pushing the boundaries of artificial intelligence by training a model on living human tissue that can be kept alive outside the body for over a month.
Polansky's journey to this point is marked by his academic and professional achievements. He studied applied mathematics and computer science at Harvard, graduating in 2006. After Harvard, he worked at Bridgewater Associates for three years, an experience he describes as unique and valuable.
Polansky's career path then took him to Silicon Valley, where he worked with Sean Parker, co-founder of Napster and former president of Facebook. He was a principal at Founders Fund and also ran Parker's family office. Currently, he serves as the executive director of the Parker Institute for Cancer Immunotherapy.
## What's at stake The ability to keep living human tissue alive outside the body for an extended period has significant implications for medical research and potential treatments. By training an AI model on such tissue, Outer Biosciences may uncover new insights into human biology and disease. This innovative approach could lead to breakthroughs in various fields, including cancer immunotherapy, which is a focus of the Parker Institute.
## Background and context Polansky's work at Outer Biosciences represents a convergence of his technical expertise and his passion for advancing medical research. His partnership with Lady Gaga, a renowned artist and philanthropist, highlights the intersection of technology, art, and science. As the founder of Outer Biosciences, Polansky is driving innovation in the field of AI and biology, with the potential to impact human health and wellbeing.
The use of living human tissue in AI research raises important questions about the future of medical research and the potential applications of such technology. As Outer Biosciences continues to advance its research, it will be important to consider the ethical implications and potential benefits of this innovative approach.





